UBQU (Ubiquitech Software) EBITDA Margin %: -38.10% (As of Aug. 2023)


What is Ubiquitech Software EBITDA Margin %?

Ubiquitech Software UBQU -95.00% EBITDA Margin % is -38.10% as of Aug. 2023.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ubiquitech Software's EBITDA for the three months ended in Aug. 2023 was $-0.02 Mil. Ubiquitech Software's Revenue for the three months ended in Aug. 2023 was $0.04 Mil. Therefore, Ubiquitech Software's EBITDA margin for the quarter that ended in Aug. 2023 was -38.10%.

Ubiquitech Software  (OTCPK:UBQU) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Ubiquitech Software EBITDA Margin % Related Terms

Ubiquitech Software EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Ubiquitech Software's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ubiquitech Software EBITDA Margin % Chart

Ubiquitech Software Annual Data
Trend Aug08
EBITDA Margin %
0.00

Ubiquitech Software Quarterly Data
Nov07 Feb08 May08 Aug08 Nov08 Feb09 May09 Aug09 Nov09 Feb10 May10 Aug22 Aug23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -194.87 -38.10

UBQU vs ZTS: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ubiquitech Software's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ubiquitech Software EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ubiquitech Software's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Ubiquitech Software's EBITDA Margin % falls into.


Ubiquitech Software EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Ubiquitech Software's EBITDA Margin % for the fiscal year that ended in Aug. 2008 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2008 )/Revenue (A: Aug. 2008 )
=-0.024/0
= %

Ubiquitech Software's EBITDA Margin % for the quarter that ended in Aug. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Aug. 2023 )/Revenue (Q: Aug. 2023 )
=-0.016/0.042
=-38.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -38.10% mean?
Ubiquitech Software (UBQU) has a EBITDA Margin % of -38.10% as of Aug. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ubiquitech Software and its competitors.
Is Ubiquitech Software's EBITDA Margin % too high?
Ubiquitech Software's current EBITDA Margin % is -38.10%.
How does Ubiquitech Software's EBITDA Margin % compare to ZTS?
Ubiquitech Software's EBITDA Margin % of -38.10% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ubiquitech Software and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ubiquitech Software's current EBITDA Margin % is -38.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ubiquitech Software stock overvalued right now?
Ubiquitech Software (UBQU) has a current EBITDA Margin % of -38.10%. The current EBITDA Margin % is -38.10%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ubiquitech Software (UBQU), the current EBITDA Margin % is -38.10% as of Aug. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ubiquitech Software Business Description

Address 3570 East 12th Avenue, Denver, CO, USA, 80206
Ubiquitech Software Corp is a United States-based multi-media, multi-faceted company. It is engaged in utilizing world-wide internet marketing, direct response television, radio, and traditional marketing to drive traffic to the new industries. The company also focuses on developing Cannabidiol (CBD) Hemp derived products. It owns the proprietary CBD brand CannazALL. The company offers the products through its internally designed and operated web portal.